Baxter International | BAX - Ebit


Baxter International reported $66M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Avanos Medical USD 8.9M 15.87M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Cooper Companies USD -31M 243.8M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fresenius EUR 713M 139M Dec/2025
Globus Medical USD 164M 17.31M Mar/2026
Halozyme Therapeutics USD -61.77M 26.64M Mar/2026
ICU Medical USD 26.09M 770K Dec/2025
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.51B Mar/2026
Laboratory Of America USD 410.1M 28.1M Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Quest Diagnostics USD 399M 13M Mar/2026
Smith & Nephew USD 440M 50M Dec/2025
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026